Total planned funding: $581,061,618
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $581,061,618 |
Organizational Types
NGO | $162,008,704 |
Private Contractor | $108,761,204 |
Own Agency | $76,009,021 |
Host Country Government Agency | $70,089,188 |
Unknown | $66,617,826 |
University | $62,781,501 |
Parastatal | $14,119,589 |
Implementing Agency | $8,482,984 |
Other USG Agency | $5,969,768 |
Multi-lateral Agency | $4,330,195 |
FBO | $1,891,638 |
Program Areas
Treatment | $168,373,908 |
Prevention | $121,188,189 |
Care | $119,960,934 |
Governance and Systems | $78,662,610 |
Management and Operations | $50,548,998 |
Testing | $42,326,979 |
Budget Codes
HTXS: Treatment: Adult Treatment | $142,558,687 |
HVMS: Management and Operations | $50,548,998 |
HKID: Care: Orphans and Vulnerable Children | $49,505,629 |
HVCT: Testing: HIV Testing and Counseling | $42,326,979 |
HVOP: Sexual Prevention: Other Sexual Prevention | $40,356,575 |
HBHC: Care: Adult Care and Support | $35,264,253 |
HVSI: Strategic Information | $34,622,852 |
OHSS: Health Systems Strengthening | $32,760,399 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $29,649,843 |
HVTB: Care: TB/HIV | $22,875,466 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $22,789,609 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $20,776,733 |
PDTX: Treatment: Pediatric Treatment | $13,449,633 |
HTXD: Treatment: ARV Drugs | $12,365,588 |
PDCS: Care: Pediatric Care and Support | $12,315,586 |
HLAB: Laboratory Infrastructure | $11,279,359 |
HMBL: Biomedical Prevention: Blood Safety | $5,508,997 |
HMIN: Biomedical Prevention: Injection Safety | $2,106,432 |
Top Partner Programs
Potentia Namibia:
$64,995,398
Countries/Regions
Not Available:
$50,615,216
Countries/Regions
University of Washington:
$48,009,461
Countries/Regions
USG Aggregated Agencies:
$42,306,405
Countries/Regions